COVID-19 and Parkinson’s disease: a casual association or a possible second hit in neurodegeneration?
暂无分享,去创建一个
E. Moro | M. Zedde | R. Pascarella | A. Versari | F. Valzania | A. Fraternali | F. Cavallieri | M. Casali | P. Bauer | M. Napoli | Giulia Toschi | V. Fioravanti | Jefri J Paul | C. Moratti | S. Grisanti | Jefri J. Paul
[1] J. Jankovic,et al. Parkinson's disease after COVID-19 , 2021, Journal of the Neurological Sciences.
[2] J. Obeso,et al. SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy , 2020, The Lancet Neurology.
[3] N. Bornstein,et al. A case of probable Parkinson's disease after SARS-CoV-2 infection , 2020, The Lancet Neurology.
[4] A. Sette,et al. COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside , 2020, npj Parkinson's Disease.
[5] A. Sette,et al. COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside , 2020, npj Parkinson's Disease.
[6] A. Pisani,et al. Double hit mouse model of Parkinson's disease , 2016, Oncotarget.
[7] G. Deuschl,et al. MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[8] A. Lang,et al. Deciphering the role of heterozygous mutations in genes associated with parkinsonism , 2007, The Lancet Neurology.